The Company is a biopharmaceutical company developing novel peptide-based drug candidates to improve the treatment of serious and often life-threatening conditions.
The best Bull and Bear pitches based on recency and number of recommendations.
Hematide will get approved in the dialysis setting where its phase 3 clinical trials showed a trend toward superiority when compared with aranesp. The dialysis market is much larger than the non-dialysis market
Affymax is a biopharmaceutical company creating peptide-based drugs to improve the treatment of serious and often life-threatening conditions. The company was spun out from GlaxoSmithKline in 2001. The company does not have any approved product in… More
Read the most recent pitches from players about AFFY.
Recs
All of AFFY egg's are in one basket > Omontys, check it out Omontys is off the market.
my pick GILD
Recs
Drug will B reinstated
Recs
Price Target: $8
Find the members with the highest scoring picks in AFFY.
qubit15 (27.50) Score: +640.78
The Score Leader is the player with the highest score across all their picks in AFFY.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
qubit15 | 27.50 | 1/21/2009 | NS | $7.32 | -99.99% | +540.79% | +640.78 | 0 Comment | ||
heftyjeffy | < 20 | 1/26/2009 | 1Y | $7.38 | -99.99% | +524.36% | +624.35 | 0 Comment | ||
anticitradeshort | 30.04 | 4/20/2009 | NS | $11.53 | -99.99% | +505.80% | +605.79 | 0 Comment | ||
NapoleonDynamite | 46.51 | 5/1/2009 | NS | $11.25 | -99.99% | +489.70% | +589.69 | 0 Comment | ||
KeepYourCoolFool | 93.45 | 5/14/2009 | 5Y | $10.66 | -99.99% | +484.07% | +584.07 | 0 Comment | ||
lanceur | 30.29 | 5/21/2009 | 5Y | $10.79 | -99.99% | +479.26% | +579.25 | 0 Comment | ||
soul2197 | 99.33 | 6/25/2009 | 3W | $11.69 | -99.99% | +474.69% | +574.68 | 0 Comment | ||
Nivaos | 73.24 | 8/17/2009 | 1Y | $12.69 | -99.99% | +421.32% | +521.31 | 0 Comment | ||
SavantTheIdiot | 99.92 | 10/13/2009 | NS | $15.43 | -100.00% | +377.57% | +477.56 | 0 Comment | ||
punchy22 | < 20 | 6/28/2010 | 3W | $4.50 | -99.98% | +374.30% | +474.28 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.